specialized consultants to provide a feasibility review and develop a business plan for development of a viral vector manufacturing facility in a current cell manufacturing facility

The National Institutes of Health (NIH) is seeking specialized consultants to provide a feasibility review and develop a business plan for the development of a viral vector manufacturing facility in a current cell manufacturing facility. The manufacturing will encompass retroviral/lentiviral vectors, AAV, and transition to future nanoparticles for Phase I and early Phase II studies conducted at the NIH Clinical Center. • The project involves developing a business plan for a viral vector manufacturing facility. • The facility will be used for manufacturing retroviral/lentiviral vectors, AAV, and future nanoparticles. • The project is for Phase I and early Phase II studies conducted at the NIH Clinical Center. • Interested parties may identify their interest and capabilities in response to this posting.